Carefully consider and monitor bevacizumab use
Using bevacizumab in combination with chemotherapy or biological therapy raises the risk of treatment-related death—but the agent’s potential benefits may outweigh the relatively low absolute risk.
Diagnosis & Disease Information
Geography a factor in colorectal screening rates
The disparities seen in colorectal cancer screening rates appear to be linked not only to racial/ethnic factors but also geography, according to a study of screening status among Medicare enrollees.
People are willing to pay for test that predicts their cancer future
Most adults would pay for lab tests that would show their risks for breast and prostate cancers as well as arthritis and Alzheimer disease, even if the tests were not perfectly accurate and did not have direct treatment consequences.
TPF better than PF regimen for HNC
A three-drug treatment for head and neck cancer (HNC) improves long-term survival so significantly that researchers are calling for the trio to become the standard of care for patients suitable for first-line therapy.
IMRT a less toxic form of radiation in anal cancer
A novel chemoradiation regimen for the treatment of anal cancer is proven to have fewer significant side effects than conventional therapy.
New method detects residual cancer cells
Amplicon fusion sites polymerase chain reaction (AFS-PCR) assay can detect and quantify human neuroblastoma cells in human blood and bone marrow samples.
Cancer costs will reach or exceed $158 billion in 2020
If the US population ages at the rate predicted by the US Census Bureau and cancer incidence, survival rates, and costs remain stable, in the year 2020 direct cancer care expenditures will reach $157.77 billion in 2010 dollars.
Inhibiting “anchor” molecule in stem cells may improve marrow transplant process
The safety and efficiency of bone marrow transplants may improve due to the discovery of a rare molecule that establishes blood stem cells in their niche within the bone marrow.
Estrogen role in head and neck cancer explored
Estrogen may promote the spread of head and neck cancer by increasing the movement of precancerous cells in the mouth, suggest new study findings.
Evidence links KRAS mutations to poor survival in colorectal cancer
KRAS gene mutations are strong predictors of reduced overall and progression-free survival and greater treatment failure in patients with advanced colorectal cancer undergoing anti-EGFR therapy.
- Loading...
Loading...
Loading... 
Loading...